Delivery Order SPE2DB22D3501-SPE2DB23FWU16

Award Date 8/8/23
Potential Completion Date 8/9/23
Potential Value $897
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $12,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 boxes containing 80mg tablets of atorvastatin. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on August 14, 2023 and ending on August 15, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global...
The Defense Logistics Agency awarded a $414,810 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 bottles of atorvastatin 40 mg tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order was placed on September 5, 2023 under an indefinite-delivery/indefinite-quantity contract vehicle and is to be completed by September 6, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency...
The Defense Logistics Agency awarded a $3,368 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 bottles of atorvastatin 40 mg tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order was placed on September 13, 2023 under an existing contract vehicle and runs through September 14, 2023. As a major provider of pharmaceuticals to the Department of Defense, this order will help the Defense Logistics Agency meet demand...
The Defense Logistics Agency awarded a $298.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 tablets of 80mg atorvastatin. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by July 31, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure medical supplies such as atorvastatin are available to support military readiness. No subcontractors or set...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-four thousand six hundred and sixty-four dollars to Amerisourcebergen Drug Corporation for the supply of ninety boxes containing eighty milligram tablets of atorvastatin. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance spans from August 15, 2023 through August 16, 2023. No subcontractors or set aside designations were identified. The...
The Defense Logistics Agency awarded a $83,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 boxes containing 20 mg tablets of atorvastatin. The place of performance is Conshohocken, Pennsylvania. The delivery order has a period of performance from June 29, 2023 through June 30, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply chain for the United States Department of...
The Defense Logistics Agency awarded a $150,150 delivery order to Amerisourcebergen Drug Corporation for the provision of 4561688100 Atorvastatin 40 mg tablets, 90 count each. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle and will be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by August 4, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. military worldwide, this order supports the...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-four thousand six hundred and forty dollars to Amerisourcebergen Drug Corporation for the supply of atorvastatin tablets. As the prime contractor, Amerisourcebergen will deliver 4561479004 units of the 80mg atorvastatin medication to a location in Conshohocken, Pennsylvania over a period of one day, from July 12th through July 13th, 2023. The Defense Logistics Agency is the Department of Defense's combat...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifty thousand eighty-four dollars to Amerisourcebergen Drug Corporation for the supply of atorvastatin tablets. Under this order, Amerisourcebergen will deliver one hundred tablets of the generic cholesterol medication atorvastatin in ten milligram dosage to a location in Conshohocken, Pennsylvania by July 25, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $242.76 to Amerisourcebergen Drug Corp for the supply of 1,000 tablets of 40mg atorvastatin. The order is to be performed in Conshohocken, Pennsylvania by July 24, 2023, with the Defense Logistics Agency as the funding agency. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor to fulfill this order for the generic cholesterol medication. No...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB23FWU16
    Delivery Order

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $897 to Amerisourcebergen Drug Corporation for the supply of 4561741991 Atorvastatin 80 mg tablets in unit dose packages of 30 tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The single day order period is from August 8 to August 9, 2023. The Defense Logistics Agency functions to provide logistics support to the United States Department of Defense and this order for the cholesterol-lowering drug Atorvastatin is likely to support the medical treatment and readiness of military personnel. No subcontractors or set aside designations were indicated in the award information provided.

Generated 12/23/23, 4:51 AM